Saturday 17 October 2026
Export CHRS’s income statement to Excel — free account
Coherus Oncology, Inc.
CHRS Healthcare Biotechnology
In the quarter to June 2026, revenue grew 39.5%, EPS fell 105.1%, free cash flow fell 33.2% and total debt rose 1.03%, each against the same quarter a year earlier.
1.00
0.07
−6.54%
Follow CHRS
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 5 | 6 | 4 |
+8 more TTM periods Free account |
| (146.27%) | (355.31%) | (473.47%) | (155,671.52%) | ||
| (41.90%) | 58.47% | 47.54% | 30.34% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(223.41%) | 249.03% | 248.32% | 171.64% | |
Average Days of Receivables |
102.13 | 175.25 | 159.41 | 2,460.67 | |
Free Cash Flow per Share |
(1.20) | (1.25) | (1.18) | (0.78) | |
Free Cash Flow |
(186.03) | (170.57) | (138.51) | (90.19) | |
| Other line items | |||||
Cash ROIC |
(91.46%) | (60.31%) | (51.27%) | (28.51%) | |
Accounts Receivable Turnover |
0.76 | 1.10 | 0.60 | 0.17 | |
Accounts Payable Turnover |
0.62 | 0.57 | 0.72 | 0.54 | |
Inventory Turnover |
3.11 | 3.59 | 3.74 | 0.50 | |
Average Days of Payables |
303.77 | 279.79 | 261.98 | 725.77 | |
Days of Inventory on Hand |
130.73 | 117.60 | 83.81 | 59.71 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
198.70% | 226.25% | 258.20% | 265.56% | |
Selling, General and Administrative Expense of Revenue |
181.79% | 208.35% | 238.56% | 286.90% | |
Share Based Compensation of Revenue |
21.87% | 29.82% | 40.23% | 55.35% | |
Interest Coverage |
(17.47) | (19.02) | (20.12) | (24.15) | |
Operating CF/Net income |
1.41 | (0.92) | (0.82) | (0.58) | |
Depreciation/Fixed assets |
4.17 | 3.44 | 2.92 | 2.49 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.33 | 0.34 | 0.36 | 0.32 | |
Operating CF per Share |
(1.20) | (1.25) | (1.18) | (0.78) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates